Six-pattern p53 interpretation in 1293 vulvar squamous cell carcinomas: inter-pathologist variation and pattern distribution according to p16 status.

IF 4.1 2区 医学 Q2 CELL BIOLOGY
Histopathology Pub Date : 2025-09-18 DOI:10.1111/his.15561
Emma L Kaderly Rasmussen, Susanne K Kjær, Lise G Larsen, Else Mejlgaard, Maria B Franzmann, Alexander K Kjær, Nadia V Salinas, Doris Schledermann, Kirsten Frederiksen, Tatiana Hansen, Birgitte H Winberg, Marianne Waldstrøm, Louise Baandrup
{"title":"Six-pattern p53 interpretation in 1293 vulvar squamous cell carcinomas: inter-pathologist variation and pattern distribution according to p16 status.","authors":"Emma L Kaderly Rasmussen, Susanne K Kjær, Lise G Larsen, Else Mejlgaard, Maria B Franzmann, Alexander K Kjær, Nadia V Salinas, Doris Schledermann, Kirsten Frederiksen, Tatiana Hansen, Birgitte H Winberg, Marianne Waldstrøm, Louise Baandrup","doi":"10.1111/his.15561","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Vulvar squamous cell carcinoma (VSCC) is classified into human papillomavirus (HPV)-associated and HPV-independent types, primarily using p16 immunohistochemistry, with p53 staining playing a complementary role since a subset of HPV-independent VSCC is driven by TP53 mutations. We aimed to assess the robustness of the six-pattern p53 classification by evaluating interobserver agreement and mapping pattern distribution in relation to p16 status.</p><p><strong>Methods: </strong>We performed p53 immunohistochemistry on 1293 VSCC cases, comprising 832 p16-negative and 461 p16-positive cases. Eight pathologists independently evaluated p53, with each case assessed by two pathologists. Expression was classified as wild-type (scattered or mid-epithelial) or mutated (basal overexpression, parabasal/diffuse overexpression, absent or cytoplasmic). Interobserver agreement was measured using kappa statistics.</p><p><strong>Results: </strong>Overall concordance across the six p53 patterns was 66.7%, increasing to 86.9% when dichotomized as wild-type versus mutated. In the p16-negative cases, concordance was 68.8% across all six patterns and 82.6% when dichotomized. Corresponding rates in the p16-positive cases were 62.9% and 94.6%. Kappa values for pairwise assessments ranged from 0.44 to 0.73 (six-pattern) and from 0.60 to 0.88 (dichotomized). After resolving discordant cases, 79.9% of p16-negative cases showed a mutated pattern, and 20.1% were wild type (scattered). Among the p16-positive cases, 93.1% exhibited a wild-type pattern.</p><p><strong>Conclusions: </strong>Findings support the clinical robustness of the six-pattern p53 framework, as interobserver agreement was high and most discrepancies were unlikely to impact tumour classification. While p16 proved helpful in p53 interpretation, certain cases remained challenging due to p53 heterogeneity or ambiguous p16/p53 combinations indicating a need for additional molecular testing in such instances.</p>","PeriodicalId":13219,"journal":{"name":"Histopathology","volume":" ","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Histopathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/his.15561","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: Vulvar squamous cell carcinoma (VSCC) is classified into human papillomavirus (HPV)-associated and HPV-independent types, primarily using p16 immunohistochemistry, with p53 staining playing a complementary role since a subset of HPV-independent VSCC is driven by TP53 mutations. We aimed to assess the robustness of the six-pattern p53 classification by evaluating interobserver agreement and mapping pattern distribution in relation to p16 status.

Methods: We performed p53 immunohistochemistry on 1293 VSCC cases, comprising 832 p16-negative and 461 p16-positive cases. Eight pathologists independently evaluated p53, with each case assessed by two pathologists. Expression was classified as wild-type (scattered or mid-epithelial) or mutated (basal overexpression, parabasal/diffuse overexpression, absent or cytoplasmic). Interobserver agreement was measured using kappa statistics.

Results: Overall concordance across the six p53 patterns was 66.7%, increasing to 86.9% when dichotomized as wild-type versus mutated. In the p16-negative cases, concordance was 68.8% across all six patterns and 82.6% when dichotomized. Corresponding rates in the p16-positive cases were 62.9% and 94.6%. Kappa values for pairwise assessments ranged from 0.44 to 0.73 (six-pattern) and from 0.60 to 0.88 (dichotomized). After resolving discordant cases, 79.9% of p16-negative cases showed a mutated pattern, and 20.1% were wild type (scattered). Among the p16-positive cases, 93.1% exhibited a wild-type pattern.

Conclusions: Findings support the clinical robustness of the six-pattern p53 framework, as interobserver agreement was high and most discrepancies were unlikely to impact tumour classification. While p16 proved helpful in p53 interpretation, certain cases remained challenging due to p53 heterogeneity or ambiguous p16/p53 combinations indicating a need for additional molecular testing in such instances.

1293例外阴鳞状细胞癌中p53的六型解释:病理间变异及p16状态的模式分布
目的:外阴鳞状细胞癌(VSCC)分为人乳头瘤病毒(HPV)相关型和HPV非依赖型,主要使用p16免疫组化,p53染色起补充作用,因为HPV非依赖型VSCC的一个子集是由TP53突变驱动的。我们旨在通过评估观察者之间的一致性和与p16状态相关的模式分布来评估六模式p53分类的稳健性。方法:对1293例VSCC患者进行p53免疫组化,其中p16阴性832例,p16阳性461例。8名病理学家独立评估p53,每个病例由2名病理学家评估。表达分为野生型(分散或中上皮)或突变型(基底过表达、旁基底/弥漫性过表达、缺失或细胞质)。使用kappa统计来测量观察者间的一致性。结果:6种p53基因型的总体一致性为66.7%,野生型和突变型的一致性增加到86.9%。在p16阴性的病例中,所有六种模式的一致性为68.8%,二分类时为82.6%。p16阳性患者相应比例分别为62.9%和94.6%。两两评估的Kappa值范围为0.44至0.73(六模式)和0.60至0.88(二分类)。在排除不一致病例后,79.9%的p16阴性病例显示突变型,20.1%为野生型(分散)。在p16阳性的病例中,93.1%表现为野生型。结论:研究结果支持六模式p53框架的临床稳健性,因为观察者之间的一致性很高,大多数差异不太可能影响肿瘤分类。虽然p16被证明有助于解释p53,但由于p53异质性或p16/p53组合不明确,某些病例仍然具有挑战性,这表明在这种情况下需要额外的分子检测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Histopathology
Histopathology 医学-病理学
CiteScore
10.20
自引率
4.70%
发文量
239
审稿时长
1 months
期刊介绍: Histopathology is an international journal intended to be of practical value to surgical and diagnostic histopathologists, and to investigators of human disease who employ histopathological methods. Our primary purpose is to publish advances in pathology, in particular those applicable to clinical practice and contributing to the better understanding of human disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信